Skip to main content
OpenTrials
Completed

NCT Number: NCT06173050

PAP Systems Internal Clinical Studies (ICS)

This is a pre-market study for ongoing product development aiming to explore the usability and performance of the study PAP systems to guide product development.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–130 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Resmed Asia Pacific Pte Ltd

Singapore

About this study

This is an open label, prospective, randomized cross over (or single arm) study designed to support the development of new accessories for PAP devices. This generic protocol provides a framework methodology for how these ongoing studies will be conducted. This protocol then is used in a number of smaller sub-studies, each of which will have their own sub-protocol outlining the exact specifics of the study.

The studies could be run face-to-face or remotely.

Participants are healthy volunteers who are ResMed employees. Recruitment will be done via emails. Participants will be explained the details of the trial and those who wish to take part will be invited to a selected site for the first study visit.

Visit 1: Participants will provide written informed consent. Participants will be shown the PAP systems and trial them for fit and comfort. Participants may be asked initial questions on their first thoughts on the PAP systems. If the participant and assessor are happy to proceed, the participants will use the loan PAP system for trial.

Visit 2: After trialing the PAP systems, participants will be asked to complete a questionnaire regarding the appeal, comfort, and usability of the PAP system(s). Depending on sub-study protocol, participants will then take the second PAP system home to test.

Visit 3: The participant will return the loan PAP system to the assessor. The participants' questionnaire responses will be reviewed. This concludes the participation in the study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants who are employees of ResMed
  • Participants shall be volunteers
  • Participants willing to give written informed consent
  • Participants who ≥ 18 years of age
  • Participants willing and able to complete the specified tasks

Exclusion criteria

  • Participants who are or may be pregnant.
  • Participants with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury.
  • Participants believed to be unsuitable for inclusion by the researcher.
  • Participants who or whose bed partner has implantable medical devices which may contraindicate against masks with magnetic clips (exclusion criteria for study masks with magnetic clips only)

Treatment and study plan

PAP System A (with Amalfi) then PAP System B (with CLA11)

Device

PAP System A (with Amalfi) for 7 days followed by PAP System B (with CLA11) for 7 days

PAP System B (with CLA11) then PAP System A (with Amalfi)

Device

PAP System B (with CLA11) for 7 days followed by PAP System A (with Amalfi) for 7 days

Primary outcomes

  1. Subjective outcomes parameters scores

    Time frame: 6 weeks

    Subjective outcomes parameters scores from participants. Each subjective outcomes item of the investigational component/s of the PAP System will be rated on a Likert Scale questionnaire. Scores will be collected using an 11-point Likert Scale Questionnaire. Minimum value will be zero. Maximum value will be 10. A higher score indicates better outcomes. A score of 10 is considered very favorable, and a score of 0 is very unfavorable.

Sponsors and collaborators

Lead sponsor

ResMed

Industry

Registry information

Official study title

Internal Evaluation of PAP Systems: Comparison of PAP Flow Generators Machines, Mask Systems and Tubing

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Dec 15, 2023
Registry last updated
Apr 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.